BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11164438)

  • 1. Comparison of the measurement of lipids and lipoproteins versus assay of apolipoprotein B for estimation of coronary heart disease risk: a study in familial combined hyperlipidemia.
    Demacker PN; Veerkamp MJ; Bredie SJ; Marcovina SM; de Graaf J; Stalenhoef AF
    Atherosclerosis; 2000 Dec; 153(2):483-90. PubMed ID: 11164438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bimodality of plasma apolipoprotein B levels in familial combined hyperlipidemia.
    Austin MA; Horowitz H; Wijsman E; Krauss RM; Brunzell J
    Atherosclerosis; 1992 Jan; 92(1):67-77. PubMed ID: 1575822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability.
    Bredie SJ; de Bruin TW; Demacker PN; Kastelein JJ; Stalenhoef AF
    Am J Cardiol; 1995 Feb; 75(5):348-53. PubMed ID: 7856526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of atorvastatin on postprandial plasma lipoproteins in postinfarction patients with combined hyperlipidaemia.
    Boquist S; Karpe F; Danell-Toverud K; Hamsten A
    Atherosclerosis; 2002 May; 162(1):163-70. PubMed ID: 11947910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E polymorphism influences lipid phenotypic expression, but not the low density lipoprotein subfraction distribution in familial combined hyperlipidemia.
    Bredie SJ; Vogelaar JM; Demacker PN; Stalenhoef AF
    Atherosclerosis; 1996 Oct; 126(2):313-24. PubMed ID: 8902157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study.
    Veerkamp MJ; de Graaf J; Bredie SJ; Hendriks JC; Demacker PN; Stalenhoef AF
    Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):274-82. PubMed ID: 11834528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma homocysteine in subjects with familial combined hyperlipidemia.
    Veerkamp MJ; de Graaf J; den Heijer M; Blom HJ; Stalenhoef AF
    Atherosclerosis; 2003 Jan; 166(1):111-7. PubMed ID: 12482557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
    Zambon A; Brown BG; Deeb SS; Brunzell JD
    J Intern Med; 2006 May; 259(5):473-80. PubMed ID: 16629853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro lipolysis of human VLDL: effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia.
    van Barlingen HH; Kock LA; de Man FH; Erkelens DW; de Bruin TW
    Atherosclerosis; 1996 Mar; 121(1):75-84. PubMed ID: 8678926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
    Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
    Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of children and coronary heart disease patients with low high density lipoprotein cholesterol levels.
    Ohta T; Saku K; Nakamura R; Maung KK; Matsuda I
    Atherosclerosis; 1998 Apr; 137(2):321-8. PubMed ID: 9622275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of angiographically defined coronary artery disease and plasma concentrations of insulin, lipid, and apolipoprotein in normolipidemic subjects with varying degrees of glucose tolerance.
    Fujiwara R; Kutsumi Y; Hayashi T; Nishio H; Koshino Y; Shimada Y; Nakai T; Miyabo S
    Am J Cardiol; 1995 Jan; 75(2):122-6. PubMed ID: 7810485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of micronized fenofibrate on lipid parameters and fibrinogen in heterozygous familial hypercholesterolemia and familial combined hyperlipidemia].
    Ceska R; Sobra J; Kvasnicka J; Procházková R; Kvasilová M; Haas T
    Cas Lek Cesk; 1996 Jul; 135(13):413-6. PubMed ID: 8925538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study.
    Veerkamp MJ; de Graaf J; Hendriks JC; Demacker PN; Stalenhoef AF
    Circulation; 2004 Jun; 109(24):2980-5. PubMed ID: 15184285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Segregation analysis of plasma apolipoprotein B levels in familial combined hyperlipidemia.
    Bredie SJ; van Drongelen J; Kiemeney LA; Demacker PN; Beaty TH; Stalenhoef AF
    Arterioscler Thromb Vasc Biol; 1997 May; 17(5):834-40. PubMed ID: 9157945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex hormones, lipids, lipoprotein cholesterols, and apolipoproteins in normal and obese subjects: atherogenic relationships.
    Mendoza SG; Zerpa A; Velazquez E; Schwarzenberg A; Hynd B; Kashyap ML; Laskarzewski P; Glueck CJ
    Int J Obes; 1986; 10(6):427-41. PubMed ID: 3100468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parabolic relationship between plasma triacylglycerols and LDL-cholesterol in familial combined hyperlipidaemia: the multiple-type hyperlipidaemia explained?
    Brouwers MC; de Graaf J; van Greevenbroek MM; Georgieva AM; van der Kallen CJ; Ter Avest E; Stehouwer CD; Stalenhoef AF; de Bruin TW
    Clin Sci (Lond); 2008 Mar; 114(5):393-401. PubMed ID: 17953518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of serum lipids, apolipoproteins A-I and B and pseudocholinesterase activity and their discriminative values in patients with coronary by-pass operation.
    Lehtonen A; Marniemi J; Inberg M; Maatela J; Alanen E; Niittymäki K
    Atherosclerosis; 1986 Feb; 59(2):215-21. PubMed ID: 3083832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperapo-beta-emia in children. Study of 17 families].
    Sarriá Chueca A; Moreno Aznar L; Mur Llorente M; Lázaro Almarza A; Roda Altes L; Giner Soria A; Bueno Sánchez M
    An Esp Pediatr; 1992 Jul; 37(1):52-6. PubMed ID: 1416524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.